Covid-19: Johnson & Johnson halts coronavirus vaccine trial following ‘unexplained’ illness in a trial participant
Pharma company Johnson & Johnson has temporarily halted its coronavirus vaccine trial following an ‘unexplained’ illness in a trial participant. The Phase 3 trial aims to enroll up to 60,000 people across 200 sites worldwide. …
